BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 683637)

  • 21. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pregnancy and puerperium after treated hyperprolactinemia].
    Rjosk HK; von Werder K
    Gynakologe; 1982 Mar; 15(1):22-9. PubMed ID: 7042489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial or complete regression of hyperprolactinemic amenorrhea-galactorrhea syndrome after bromocriptine-induced pregnancy.
    Molinatti GM; Campagnoli C; Belforte L; Massara F; Peris C; Pinna N
    Panminerva Med; 1980; 22(3):125-30. PubMed ID: 7208090
    [No Abstract]   [Full Text] [Related]  

  • 25. Symptomatic pituitary tumor enlargement after induced pregnancy. Case report.
    Nelson PB; Robinson AG; Archer DF; Maroon JC
    J Neurosurg; 1978 Aug; 49(2):283-7. PubMed ID: 671082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
    Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
    J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous and induced pregnancies in hyperprolactinemic women.
    Crosignani PG; Ferrari C; Scarduelli C; Picciotti MC; Caldara R; Malinverni A
    Obstet Gynecol; 1981 Dec; 58(6):708-13. PubMed ID: 6796919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

  • 29. The amenorrhea galactorrhea syndrome.
    Ngan A; Wong WP
    Singapore Med J; 1978 Sep; 19(3):132-7. PubMed ID: 751196
    [No Abstract]   [Full Text] [Related]  

  • 30. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction.
    Vaidya RA; Aloorkar SD; Rege NR; Maskati BT; Jahangir RP; Sheth AR; Pandya SK
    Fertil Steril; 1978 Jun; 29(6):632-6. PubMed ID: 566222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 36. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
    Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 39. Ovulatory response to clomiphene citrate during bromocriptine-failed ovulation in amenorrhea-galactorrhea and hyperprolactinemia.
    Turksoy RN; Biller BJ; Farber M; Cetrulo C; Mitchell GW
    Fertil Steril; 1982 Mar; 37(3):441-4. PubMed ID: 6800855
    [No Abstract]   [Full Text] [Related]  

  • 40. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.